Cannabidiol (CBD): Fighting Inflammation & Aggressive Forms of Cancer

“Marijuana contains at least 60 known chemicals called cannabinoids, which activate cannabinoid receptors in your body. Tetrahydrocannabinol, or THC, is the main component responsible for the psychoactive effects, or “high,” marijuana is known for. While THC is known to have some medicinal value, there has been recent investigation into a new cannabinoid that is rumored to have more medicinal benefits than any single pharmaceutical drug on the market.”

“What is Cannabidiol (CBD)?

This cannabinoid is known as Cannabidiol (CBD), and is the second most abundant cannabinoid in cannabis. Research done by G.W. Pharmaceuticals suggests that CBD could be used for treating symptoms of rheumatoid arthritis and other autoimmune diseases, diabetes, nausea, bowel disorders, and many other hard-to-control side effects. According to an article from Projectcbd.com, CBD has even demonstrated neuroprotective effects, and its anti-cancer potential is currently being explored.

While it was originally believed that THC is a breakdown product of CBD, it is now known that both THC and CBD are actually metabolites of their decarboxylated acidic forms, THCa and CBDa. These acidic precursors are decarboxylated (essentially dried) by heat or extraction to produce THC and CBD; only then do they become psychoactive. The compound has medicinal benefits without the “high” that some patients do not desire. This makes CBD appealing to patients who are looking for an alternative to their current meds, which often have opiate-like effects.”

More: http://www.medicaljane.com/2012/12/20/cannabidiol-cbd-medicine-of-the-future/

Cannabis News: The Cannabinoid System Reverses Dementia, Treats PTSD and Controls Diabetes Top May’s News Digest from Publius

“The Cannabinoid System’s role in reversing dementia, treating PTSD and controlling diabetes highlight May’s cannabis news from Publius, the pen name used by the authors of The Cannabis Papers – Federal ignorance goes on unabated.”

“The Cannabinoid System’s (CS) role in reversing dementia, treating PTSD and controlling diabetes highlight May’s cannabis news from Publius, the pen name used by the authors of The Cannabis Papers: A citizen’s guide to cannabinoids (2011).”

More: http://www.prweb.com/releases/2013/5/prweb10787154.htm

The endocannabinoid system and its therapeutic exploitation.

Image result for Nat Rev Drug Discov.

“The term ‘endocannabinoid’ – originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands – now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.”  http://www.ncbi.nlm.nih.gov/pubmed/15340387

http://www.nature.com/nrd/journal/v3/n9/full/nrd1495.html

[The endocannabinoid system].

“The endocannabinoid system is a physiological system, which is responsible for the control of glucose and lipid-metabolism, as well as for the regulation of the body weight.

 The endocannabinoid receptors are distributed both in the central and peripher nervous system.

Different studies provide evidence that an hyperactive endocannabinoid system is involved in the development of different cardiovascular risk factors.

The pharmacological blockade of these cannabinoid receptors may represent a new approach for cardiometabolic risk management.””

http://www.ncbi.nlm.nih.gov/pubmed/18548817 

Marijuana: The next diabetes drug? – CNN

Toking up may help marijuana users to stay slim and lower their risk of developing diabetes, according to the latest study, which suggests that cannabis compounds may help in controlling blood sugar.”

Marijuana may help control blood sugar and help users stay slimmer, researchers say.
 

“Although marijuana has a well-deserved reputation for increasing appetite via what stoners call “the munchies,” the new research, which was published in the American Journal of Medicine, is not the first to find that the drug has a two-faced relationship to weight.

Three prior studies have shown that marijuana users are less likely to be obese, have a lower risk for diabetes and have lower body-mass-index measurements. And these trends occurred despite the fact that they seemed to take in more calories. Why?”

Read more:http://www.cnn.com/2013/05/23/health/time-marijuana-diabetes/index.html 

Cannabis use associated with lower blood sugar – Fox News

“A new study published in the American Journal of Medicine has revealed a potential benefit from the use of cannabis. The article, entitled “The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among U.S. Adults,” investigated the blood sugar-related effects of cannabis use among participants in the National Health and Nutrition Examination Survey from 2005 to 2010.”Marijuana

“The researchers found that subjects who were current cannabis users had lower levels of fasting insulin, lower levels of insulin resistance, smaller waist circumference, and higher levels of HDL cholesterol, which is known to reduce the risk of cardiovascular disease. This supported findings from earlier studies in which cannabis users showed improved weight, improved insulin resistance, and reduced incidence of diabetes, as compared with non-users.”

Read more: http://www.foxnews.com/health/2013/05/22/cannabis-use-associated-with-lower-blood-sugar/

Marijuana: The Next Diabetes Drug? – TIME

“Toking up may help marijuana users to stay slim and lower their risk of developing diabetes, according to the latest study, which suggests that cannabis compounds may help in controlling blood sugar.”
 
Close Up Of Marijuana Leaf
 

“Although marijuana has a well-deserved reputation for increasing appetite via what stoners call “the munchies,” the new research, which was published in the American Journal of Medicine, is not the first to find that the drug has a two-faced relationship to weight. Three prior studies have shown that marijuana users are less likely to be obese, have a lower risk for diabetes and have lower body-mass-index measurements. And these trends occurred despite the fact that they seemed to take in more calories.”

Read more: http://healthland.time.com/2013/05/21/marijuana-the-next-diabetes-drug/

Marijuana May Deflect Obesity

“Cannabis seems to have many different allures. It can produce a “high.” It can give the feeling of munchies. Now, it can possibly help combat obesity. Scientists recently revealed that they found two compounds from cannabis leaves that could up the total energy that the body burns.”

 

“Previous studies of two specific compounds demonstrated that they could be used to treat type-two diabetes. The compounds were also discovered to have the ability to reduce cholesterol levels in the blood stream and decrease fat in important organs such as the liver. With the aim of treating patients who have “metabolic syndrome,” the researchers are currently conducting clinical trials in 200 patients with the drug. With “metabolic syndrome,” diabetes, high blood pressure, and obesity combine to heighten the risk of heart disease and stroke in patients.”

Read more: http://www.redorbit.com/news/health/1112653330/research-finds-marijuana-may-deflect-obesity/

Cannabis – the new weight loss secret?

“Now we might know why dopers look so thin and gaunt. Cannabis facilitates weight loss!”

Cannabis

“Two cannabis compounds can raise the quantum of energy the body burns and keep obesity at bay. Called THCV and cannabidiol, they were found to have an appetite suppressing effect too for a short while. Animal tests have shown these compounds can help treat type two diabetes while also lowering levels of cholesterol in the blood stream and fat in key organs like the liver.

Scientists also found the compounds also had an impact on the level of fat and its response to insulin, a hormone that controls blood sugar levels, the Telegraph reports. THCV was also found to increase the animals’ sensitivity to insulin while also protecting the cells that produce insulin, allowing them to work better and for longer.

Steph Wright, director of research and development at GW Pharmaceuticals developing the drugs, said: “The results in animal models have been very encouraging. We are interested in how these drugs effect the fat distribution and utilisation in the body as a treatment for metabolic diseases”. We are conducting four Phase 2 clinical trials and we expect some results later this year,” Wright said. 

Tests in mice showed the compounds boosted their metabolism, leading to lower levels of fat in their livers and reduced cholesterol in their blood stream. They are now conducting clinical trials in 200 patients in the hope of producing a drug that can be used to treat patients suffering from “metabolic syndrome”, where diabetes, high blood pressure and obesity combine to increase the risk of heart disease and stroke.

Mike Cawthorne, director of metabolic research at the University of Buckingham who has been conducting the animal studies, said: “Over all, it seems these molecules increase energy expenditure in the cells of the body by increasing the metabolism”.”

http://health.india.com/news/cannabis-the-new-weight-loss-secret/

Cannabis Compounds can Help Treat Obesity

“Two cannabis compounds could be a new weapon in the fight against obesity, say researchers. Animal tests have shown these compounds can help treat type two diabetes while also lowering levels of cholesterol in the blood stream and fat in key organs like the liver.”

 Cannabis Compounds can Help Treat Obesity

“Scientists also found the compounds also had an impact on the level of fat and its response to insulin, a hormone that controls blood sugar levels, the Telegraph reports.

THCV was also found to increase the animals’ sensitivity to insulin while also protecting the cells that produce insulin, allowing them to work better and for longer.

Steph Wright, director of research and development at GW Pharmaceuticals developing the drugs, said: “The results in animal models have been very encouraging. We are interested in how these drugs effect the fat distribution and utilisation in the body as a treatment for metabolic diseases…”

Mike Cawthorne, director of metabolic research at the University of Buckingham who has been conducting the animal studies, said: “Over all, it seems these molecules increase energy expenditure in the cells of the body by increasing the metabolism”.”